Windtree Therapeutics, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 37
Rang # Quantité totale PI 38 126
Note d'activité PI 1,9/5.0    13
Rang # Activité PI 67 083
Symbole boursier WINT (nasdaq)
ISIN US97382D3035
Capitalisation 4.900M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

20 7
2 2
4 2
0
 
Dernier brevet 2024 - Intravenous istaroxime for the t...
Premier brevet 2005 - Methods to produce lung surfacta...
Dernière marque 2016 - WINDTREE THERAPEUTICS
Première marque 1995 - SURFAXIN

Industrie (Classification de Nice)

Derniers inventions, produits et services

2023 Invention Istaroxime-containing intravenous formulation for the treatment of pre-cardiogenic shock and card...
Invention Istaroxime-containing intravenous formulation for the treatment of acute heart failure (ahf). Co...
2022 Invention Intravenous istaroxime for the treatment of acute heart failure. Described herein are methods of...
Invention Intravenous istaroxime for the treatment of acute heart failure. Described herein are methods of ...
2021 Invention Istaroxime-containing intravenous formulation for the treatment of acute heart failure (ahf). Com...
2020 Invention Androstane derivatives with activity as pure or predominantly pure stimulators of serca2a for the...
Invention Inhibitors of atypical protein kinase c and their use in treating hedgehog pathway-dependent canc...
2019 Invention Istaroxime-containing intravenous formulation for the treatment of acute heart failure (ahf). (12...
2018 Invention Thienopyrimidine inhibitors of atypical protein kinase c. The present application provides a comp...
2016 P/S Pharmaceutical preparations and substances for treatment of upper and lower respiratory diseases ...
P/S Pulmonary lung surfactants for human use only
2015 Invention Azaquinazoline inhibitors of atypical protein kinase c. The present application provides a compou...
P/S Pharmaceutical preparations and substances for treatment of respiratory conditions; Medical devic...
2014 Invention Ventilation circuit adaptor and proximal aerosol delivery system. An adaptor for delivering an ae...
2013 Invention Azaquinazoline inhibitors of atypical protein kinase c. The present application provides azaquina...
Invention Lyophilization of synthetic liposomal pulmonary surfactant. Lyophilized pulmonary surfactants hav...
P/S Medical device, namely, a device which uses heat to generate aerosolized pharmaceutical preparati...
P/S Medical device, namely, a device for improving delivery of liquid, powder or aerosolized pharmace...
2011 P/S Medical devices, namely, a device for improving delivery of liquid, powder or aerosolized pharma...
2007 Invention Pulmonary surfactant formulations and methods for promoting mucus clearance. Methods and composit...
2006 Invention Surfactant treatment regimen. Regimens for the therapeutic or prophylactic administration of pulm...
2005 Invention Pulmonary surfactant formulations. Synthetic pulmonary surfactant compositions comprising dipalmi...
Invention Methods to produce lung surfactant formulations via lyophilization and formulations and uses ther...
2004 P/S Pulmonary lung surfactant.
2003 P/S pharmaceutical preparations and substances for treatment of respiratory conditions
1995 P/S pulmonary lung surfactant